Structure and activity Salbutamol
(r)-(−)-salbutamol (top) , (s)-(+)-salbutamol (bottom)
salbutamol sold racemic mixture. (r)-(−)-enantiomer (cip nomenclature) shown in image @ right (top), , responsible pharmacologic activity; (s)-(+)-enantiomer (bottom) blocks metabolic pathways associated elimination of , of pharmacologically active enantiomer (r). slower metabolism of (s)-(+)-enantiomer causes accumulate in lungs, can cause airway hyperreactivity , inflammation.
Comments
Post a Comment